{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T23:34:43Z","timestamp":1775172883467,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571173 and 81771364"],"award-info":[{"award-number":["81571173 and 81771364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501034"],"award-info":[{"award-number":["81501034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00228-019-02803-0","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T09:02:42Z","timestamp":1579338162000},"page":"659-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multiple genetic factors affecting the pharmacokinetic and pharmacodynamic processes of tacrolimus in Chinese myasthenia gravis patients"],"prefix":"10.1007","volume":"76","author":[{"given":"Huan-Yu","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Lin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Kai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Yao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Qun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1523-0338","authenticated-orcid":false,"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,18]]},"reference":[{"issue":"2","key":"2803_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3892\/ijmm.2017.2853","volume":"39","author":"Y Cao","year":"2017","unstructured":"Cao Y, Lu X, Wang J, Zhang H, Liu Z, Xu S, Wang T, Ning S, Xiao B, Wang L (2017) Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis. Int J Mol Med 39(2):268\u2013278","journal-title":"Int J Mol Med"},{"issue":"2","key":"2803_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10072-016-2769-5","volume":"38","author":"X Tao","year":"2017","unstructured":"Tao X, Wang W, Jing F, Wang Z, Chen Y, Wei D, Huang X (2017) Long-term efficacy and side effects of low-dose tacrolimus for the treatment of myasthenia gravis. Neurol Sci 38(2):325\u2013330","journal-title":"Neurol Sci"},{"issue":"2","key":"2803_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1756285615571873","volume":"8","author":"JL Cruz","year":"2015","unstructured":"Cruz JL, Wolff ML, Vanderman AJ, Brown JN (2015) The emerging role of tacrolimus in myasthenia gravis. Ther Adv Neurol Disord 8(2):92\u2013103","journal-title":"Ther Adv Neurol Disord"},{"key":"2803_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2017.08.014","volume":"77","author":"C Liu","year":"2017","unstructured":"Liu C, Gui M, Cao Y, Lin J, Li Y, Ji S, Bu B (2017) Tacrolimus improves symptoms of children with myasthenia gravis refractory to prednisone. Pediatr Neurol 77:42\u201347","journal-title":"Pediatr Neurol"},{"issue":"4","key":"2803_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.intimp.2010.12.012","volume":"11","author":"CB Zhao","year":"2011","unstructured":"Zhao CB, Zhang X, Zhang H, Hu XQ, Lu JH, Lu CZ, Xiao BG (2011) Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis. Int Immunopharmacol 11(4):519\u2013524","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"2803_CR6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/aps.2016.174","volume":"38","author":"YS Chen","year":"2017","unstructured":"Chen YS, Liu ZQ, Chen R, Wang L, Huang L, Zhu X, Zhou TY, Lu W, Ma P (2017) Population pharmacokinetic analysis of tacrolimus in Chinese myasthenia gravis patients. Acta Pharmacol Sin 38(8):1195\u20131204","journal-title":"Acta Pharmacol Sin"},{"issue":"13","key":"2803_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5414\/CNP88FX25","volume":"88","author":"G Mlinsek","year":"2017","unstructured":"Mlinsek G et al (2017) The role of single nucleotide polymorphisms of CYP3A and ABCB1 on tacrolimus predose concentration in kidney transplant recipients. Clin Nephrol 88(13):115\u2013118","journal-title":"Clin Nephrol"},{"issue":"10","key":"2803_CR8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2217\/pgs.10.105","volume":"11","author":"P Wang","year":"2010","unstructured":"Wang P, Mao Y, Razo J, Zhou X, Wong ST, Patel S, Elliott E, Shea E, Wu AH, Gaber AO (2010) Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients. Pharmacogenomics 11(10):1389\u20131402","journal-title":"Pharmacogenomics"},{"issue":"8","key":"2803_CR9","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.transproceed.2015.08.013","volume":"47","author":"N Townamchai","year":"2015","unstructured":"Townamchai N, Chancharoenthana W, Vadcharavivad S, Chariyavilaskul P, Pongpirul K, Leelahavanichkul A, Watanatorn S, Avihingsanon Y, Praditpornsilpa K, Srisawat N (2015) A simple novel technique to estimate Tacrolimus dosages during the early post kidney transplantation period. Transplant Proc 47(8):2433\u20132438","journal-title":"Transplant Proc"},{"key":"2803_CR10","doi-asserted-by":"publisher","first-page":"42192","DOI":"10.1038\/srep42192","volume":"7","author":"J Tang","year":"2017","unstructured":"Tang J et al (2017) Application of machine-learning models to predict Tacrolimus stable dose in renal transplant recipients. Sci Rep 7:42192","journal-title":"Sci Rep"},{"issue":"3","key":"2803_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/cpt.951","volume":"103","author":"JC Denny","year":"2018","unstructured":"Denny JC, van Driest S, Wei WQ, Roden DM (2018) The influence of big (clinical) data and genomics on precision medicine and drug development. Clin Pharmacol Ther 103(3):409\u2013418","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 2","key":"2803_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12920-016-0207-4","volume":"9","author":"Z Liang","year":"2016","unstructured":"Liang Z et al (2016) DL-ADR: a novel deep learning model for classifying genomic variants into adverse drug reactions. BMC Med Genomics 9(Suppl 2):48","journal-title":"BMC Med Genomics"},{"issue":"6","key":"2803_CR13","doi-asserted-by":"publisher","first-page":"6793","DOI":"10.18632\/oncotarget.23190","volume":"9","author":"Y Mao","year":"2018","unstructured":"Mao Y, Zou C, Meng F, Kong J, Wang W, Hua D (2018) The SNPs in pre-miRNA are related to the response of capecitabine-based therapy in advanced colon cancer patients. Oncotarget 9(6):6793\u20136799","journal-title":"Oncotarget"},{"issue":"Database issue","key":"2803_CR14","doi-asserted-by":"publisher","first-page":"D825","DOI":"10.1093\/nar\/gkm979","volume":"36","author":"J Reumers","year":"2008","unstructured":"Reumers J, Conde L, Medina I, Maurer-Stroh S, van Durme J, Dopazo J, Rousseau F, Schymkowitz J (2008) Joint annotation of coding and non-coding single nucleotide polymorphisms and mutations in the SNPeffect and PupaSuite databases. Nucleic Acids Res 36(Database issue):D825\u2013D829","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2803_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ncl.2018.01.006","volume":"36","author":"C Barnett","year":"2018","unstructured":"Barnett C, Herbelin L, Dimachkie MM, Barohn RJ (2018) Measuring clinical treatment response in myasthenia gravis. Neurol Clin 36(2):339\u2013353","journal-title":"Neurol Clin"},{"issue":"4","key":"2803_CR16","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1007\/s12035-016-9865-7","volume":"54","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Xu G, Cai B, Zhang H, Zhu W, Liu X (2017) Genetic variants in MicroRNAs predict recurrence of ischemic stroke. Mol Neurobiol 54(4):2776\u20132780","journal-title":"Mol Neurobiol"},{"issue":"5","key":"2803_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2217\/pgs-2017-0182","volume":"19","author":"HY Meng","year":"2018","unstructured":"Meng HY, Luo ZH, Hu B, Jin WL, Yan CK, Li ZB, Xue YY, Liu Y, Luo YE, Xu LQ, Yang H (2018) SNPs affecting the clinical outcomes of regularly used immunosuppressants. Pharmacogenomics 19(5):495\u2013511","journal-title":"Pharmacogenomics"},{"key":"2803_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijporl.2018.06.005","volume":"111","author":"G Chen","year":"2018","unstructured":"Chen G, Li MX, Wang HX, Hong JW, Shen JY, Wang Q, Shi QM, Ge X, Ding Z, Zhang JP, Xu LC (2018) Identification of key genes in cleft lip with or without cleft palate regulated by miR-199a-5p. Int J Pediatr Otorhinolaryngol 111:128\u2013137","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2803_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/1471-2164-13-661","volume":"13","author":"C Liu","year":"2012","unstructured":"Liu C et al (2012) MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics 13:661","journal-title":"BMC Genomics"},{"issue":"5","key":"2803_CR20","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.3892\/or.2017.5544","volume":"37","author":"L Li","year":"2017","unstructured":"Li L, Luo Z (2017) Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10. Oncol Rep 37(5):2679\u20132687","journal-title":"Oncol Rep"},{"issue":"5","key":"2803_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126672","volume":"10","author":"CH Chau","year":"2015","unstructured":"Chau CH, Price DK, Till C, Goodman PJ, Chen X, Leach RJ, Johnson-Pais TL, Hsing AW, Hoque A, Tangen CM, Chu L, Parnes HL, Schenk JM, Reichardt JK, Thompson IM, Figg WD (2015) Finasteride concentrations and prostate cancer risk: results from the prostate Cancer prevention trial. PLoS One 10(5):e0126672","journal-title":"PLoS One"},{"issue":"1","key":"2803_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086206","volume":"9","author":"CJ Li","year":"2014","unstructured":"Li CJ, Li L, Lin L, Jiang HX, Zhong ZY, Li WM, Zhang YJ, Zheng P, Tan XH, Zhou L (2014) Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR genetic polymorphisms on tacrolimus metabolism in Chinese renal transplant recipients. PLoS One 9(1):e86206","journal-title":"PLoS One"},{"issue":"2","key":"2803_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/jlts.2003.50023","volume":"9","author":"CE Staatz","year":"2003","unstructured":"Staatz CE, Willis C, Taylor PJ, Lynch SV, Tett SE (2003) Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transpl 9(2):130\u2013137","journal-title":"Liver Transpl"},{"issue":"8","key":"2803_CR24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00228-011-1010-y","volume":"67","author":"L Li","year":"2011","unstructured":"Li L, Li CJ, Zheng L, Zhang YJ, Jiang HX, Si-Tu B, Li ZH (2011) Tacrolimus dosing in Chinese renal transplant recipients: a population-based pharmacogenetics study. Eur J Clin Pharmacol 67(8):787\u2013795","journal-title":"Eur J Clin Pharmacol"},{"issue":"6 Pt A","key":"2803_CR25","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.clnu.2017.10.024","volume":"37","author":"B Shao","year":"2018","unstructured":"Shao B et al (2018) Vitamin D pathway gene polymorphisms influenced vitamin D level among pregnant women. Clin Nutr 37(6 Pt A):2230\u20132237","journal-title":"Clin Nutr"},{"issue":"2","key":"2803_CR26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/dmpt-2016-0036","volume":"32","author":"EY Tamashiro","year":"2017","unstructured":"Tamashiro EY, Felipe CR, Genvigir FDV, Rodrigues AC, Campos AB, Hirata RDC, Tedesco-Silva H, Medina-Pestana JO (2017) Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients. Drug Metab Pers Ther 32(2):89\u201395","journal-title":"Drug Metab Pers Ther"},{"issue":"23","key":"2803_CR27","doi-asserted-by":"publisher","first-page":"9765","DOI":"10.1158\/0008-5472.CAN-10-0130","volume":"70","author":"D Liang","year":"2010","unstructured":"Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, Gu J, Wu X, Lu K (2010) Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res 70(23):9765\u20139776","journal-title":"Cancer Res"},{"issue":"2","key":"2803_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2174\/187231211795305258","volume":"5","author":"A Ramamoorthy","year":"2011","unstructured":"Ramamoorthy A, Skaar TC (2011) In silico identification of microRNAs predicted to regulate the drug metabolizing cytochrome P450 genes. Drug Metab Lett 5(2):126\u2013131","journal-title":"Drug Metab Lett"},{"issue":"3","key":"2803_CR29","doi-asserted-by":"publisher","first-page":"e91261","DOI":"10.1371\/journal.pone.0091261","volume":"9","author":"E Lopez-Lopez","year":"2014","unstructured":"Lopez-Lopez E et al (2014) Pharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia. PLoS One 9(3):e91261","journal-title":"PLoS One"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02803-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02803-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02803-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T09:09:37Z","timestamp":1722330577000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02803-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,18]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2803"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02803-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,18]]},"assertion":[{"value":"22 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was supported by a grant from the National Natural Science Foundation of China (grant number: 81501034, 81,571,173 and 81,771,364).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest statement and funding"}},{"value":"This study has been approved by the Medical Ethics Committee of Xiangya Hospital, Central South University(Serial number: 201703107) and have therefore been performed in accordance with the ethical standards, all methods have been confirmed to follow the relevant guidelines and regulations and informed consent was obtained from all patients or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}